THC
22.2–24.6%
CBD
0.2%
Malibu is a hybrid from Chimera Seeds with THC testing between 22.2% and 24.6%, among the stronger hybrids on record.
No effect, terpene, flavor or medical-use data specific to Malibu has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
24.6% THC
About Malibu
Chimera Seeds built Malibu as a hybrid with punch rather than subtlety, and the lab numbers back that up: THC runs from 22.2% up to 24.6%, placing it well above average for the category. Beyond the breeder credit and that potency range, the public record on this cultivar is thin -- no flowering window, no yield figures, no terpene or flavor breakdown has been logged. That gap is common for newer or less-documented releases, and it means anyone picking Malibu off a shelf is buying largely on reputation and THC number alone. For a hybrid, that number alone tells a partial story, since indica and sativa traits can express themselves in dozens of ways that a single percentage never captures. Still, growers and buyers who prioritize raw potency over documented pedigree will find Malibu's THC ceiling reason enough to take notice.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Malibu
Is Malibu an Indica, Sativa, or Hybrid?
Malibu is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Malibu?
Malibu: 24.6% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.